What is the current stock price of Nuo Therapeutics, Inc. (AURX)?

As of the latest market data, Nuo Therapeutics, Inc. (AURX) is trading at $1.44. The stock has seen a loss of -15.29% today.

Does Nuo Therapeutics, Inc. (AURX) pay a dividend?

Based on current data, Nuo Therapeutics, Inc. does not have a confirmed active dividend policy.

What is the market cap of Nuo Therapeutics, Inc.?

The current market capitalization of Nuo Therapeutics, Inc. (AURX) is approximately unavailable.

AURX

Nuo Therapeutics, Inc.·Healthcare

1.44

15.294%(−0.26)

Close Price

1.50

4.167%(+0.06)

Pre-Market

Last Updated: — ET

52W L: $0.9452W H: $3.23

Company Profile

Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2017-10-24

Beta

-104.09

Websitewww.nuot.com↗